Comment and reply on: The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis.

Robinson Joan L

Curr Med Res Opin. 2009 Jul;25(7):1631-2; author reply 1632-3. doi: 10.1185/03007990902993415.

Abstract

摘要

相似文献

Curr Med Res Opin. 2009 Jul;25(7):1631-2; author reply 1632-3. doi: 10.1185/03007990902993415.

Curr Med Res Opin. 2009 Jul;25(7):1585-91. doi: 10.1185/03007990902929112.

Arch Pediatr Adolesc Med. 2000 Jan;154(1):55-61.

Pediatrics. 2004 Dec;114(6):1612-9. doi: 10.1542/peds.2004-0959.

Arch Pediatr Adolesc Med. 2006 Oct;160(10):1070-6. doi: 10.1001/archpedi.160.10.1070.

J Med Econ. 2010;13(4):705-8. doi: 10.3111/13696998.2010.535577. Epub 2010 Nov 18.

Curr Med Res Opin. 2008 Nov;24(11):3223-37. doi: 10.1185/03007990802484234. Epub 2008 Oct 16.

An Esp Pediatr. 2002 Apr;56(4):289-91.

Arch Pediatr Adolesc Med. 2007 May;161(5):519-20; author reply 520. doi: 10.1001/archpedi.161.5.519.

Respir Med. 2001 Mar;95(3):170-2. doi: 10.1053/rmed.2000.1018.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。